Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients is a research paper published in Med (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01AI151758
National Institutes of Health
Grant: PCT/FR2021/070522
Agence nationale de la recherche
Grant: ANR-10-LABX-62-IBEID
Agence nationale de la recherche
Grant: ANR-16-CONV-0005
Agence nationale de la recherche
Grant: ANR-10-LABX-77
National Institutes of Health
Grant: 3U01AI151758-03S1
Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa
Ministère des Affaires Sociales et de la Santé
Campus France
Fondation pour la Recherche Médicale
Ministry of Higher Education, Research and Innovation
Swiss Vaccine Research Institute
Institut Pasteur
Sanofi
FWCI
2.82
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals